Flu boosts heart-attack risk, says study

Sep 21, 2009

Heart problems may account for a huge share of deaths from influenza, according to a study published on Tuesday that recommends cardiac patients be vaccinated against flu.

The paper, published in the journal The Lancet , reviews mortality figures for acute myocardial infarction -- a sudden heart attack -- and cardiovascular disease during outbreaks of flu between 1932 and 2008.

The current pandemic H1N1 virus was not included in the snapshot.

Between 35 and 50 percent of the increase in deaths recorded during influenza outbreaks could be attributed to cardiovascular problems, it says.

The authors, led by infectious disease epidemiologists Charlotte Warren-Gash and Andrew Hayward at University College London, say the causes inflammation and acts on the molecular pathways that control .

These effects could destabilise fatty deposits that line the arterial wall and cause clots that block coronary arteries, they say.

Only a few investigations have been carried out into whether flu vaccination helps protect cardiac patients, but the little evidence available suggests it does, the paper says.

"We believe influenza vaccination should be encouraged wherever indicated, especially in those people with existing cardiovascular disease," it says.

At present, vaccines for "seasonal" flu are recommended in many countries for individuals with chronic medical conditions. They generally include but not other cardiac problems such as hypertension.

Relatively few people at risk take up the vaccine, though. In Britain, only 47.2 percent of people with chronic conditions received the jab for seasonal flu, according to figures quoted in the study.

(c) 2009 AFP

Explore further: Ebola 'fear factor' risks economic disaster: World Bank

add to favorites email to friend print save as pdf

Related Stories

Bird flu vaccine protects people and pets

Oct 20, 2008

A single vaccine could be used to protect chickens, cats and humans against deadly flu pandemics, according to an article published in the November issue of the Journal of General Virology. The vaccine protects birds and ma ...

Recommended for you

Nanopatch to help WHO battle polio

6 hours ago

The World Health Organisation's (WHO) battle against polio has a new weapon after joining forces with Vaxxas, the biotechnology company responsible for developing revolutionary vaccine delivery method the Nanopatch.

Obama's Ebola response: Is it enough and in time?

10 hours ago

President Barack Obama declared Tuesday that the Ebola epidemic in West Africa could threaten security around the world, and he ordered 3,000 U.S. military personnel to the region in emergency aid muscle ...

User comments : 0